Named on 6 rounds in the feed, most often in Biotech.
Rounds from 2021-07-20 to 2026-05-18
ROUNDS
6
led 1, joined 5
LED ROUNDS · USD
$50M
across 1 round
CO-INVESTORS
30
most often with Chengwei Capital
Named on 6 rounds in the feed, most often in Biotech.
Rounds from 2021-07-20 to 2026-05-18
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Full Full-Life Technologies Limited sells radiopharmaceuticals and related technologies primarily to healthcare providers. | Series D Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $110M | 2026-05-18 | [ PART ] |
Butterfly Medical A medical device company committed to reshaping the treatment of benign prostatic hyperplasia (BPH) | Series C Developing, 4 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $21M | 2026-05-14 | [ PART ] |
Full Full-Life Technologies Limited sells radiopharmaceuticals and related technologies primarily to healthcare providers. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $50M | 2025-09-29 | [ LEAD ] |
Full Full-Life Technologies Limited sells radiopharmaceuticals and related technologies primarily to healthcare providers. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $47.3M | 2024-01-03 | [ PART ] |
Full Full-Life Technologies Limited sells radiopharmaceuticals and related technologies primarily to healthcare providers. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $37M | 2022-05-26 | [ PART ] |
Leo Cancer Care Leo Cancer Care makes upright radiation therapy systems that treat cancer patients seated or standing. | Series B Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $25.3M | 2021-07-20 | [ PART ] |